Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
908 INR | +2.42% | +3.65% | -0.23% |
21/05 | Eris Lifesciences Gets Board Nod to Raise Up to INR12.50 Billion Via Bond Sale | MT |
03/04 | Eris Lifesciences Completes Acquisition of Biocon Biologics' India Formulation Business | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-0.23% | 1.47B | |
+37.78% | 705B | |
+32.82% | 583B | |
-3.51% | 364B | |
+19.94% | 332B | |
+5.14% | 291B | |
+16.64% | 238B | |
-4.13% | 210B | |
+10.63% | 209B | |
+9.32% | 169B |
- Stock Market
- Equities
- ERIS Stock
- News Eris Lifesciences Limited
- Transcript : Eris Lifesciences Limited, Q2 2024 Earnings Call, Nov 08, 2023